CTSS and cancer: Whilst there is a slew of preclinical trials describing anticancer effects of numerous inhibitors in animal models, the complexity of cathepsin functions combined with the fact that they are mostly produced by TAMs results in limited clinical evaluation of cathepsin inhibitors in cancer.